Lymphoma-induced hemophagocytic lymphohistiocytosis (HLH)– case report
Journal Title: OncoReview - Year 2011, Vol 1, Issue 4
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare (especially in adults) syndrome in which hyperinflammation leads to fever, hepatosplenomegaly, pancytopenia and when untreated leads to death. Characteristic laboratory findings include: hyperferritinemia, hypertrigliceridemia, hypofibrinogenemia, hemophagocytosis, low/absent NK-cell activity and high serum sCD25 levels. HLH in adults is in most cases secondary to viral infection (with an Epstein-Barr virus predominacy). A very rare case of T-cell lymphoma-induced HLH in an 80 year old patient is reported. This diagnosis was made when patient was already in critical condition and although after introducing treatment according to the HLH-2004 protocol (etoposide, cyclosporine A, corticosteroids) signs of improvement were observed, the outcome was fatal. Described case shows usefulness of more frequent ferritin concentration measurements in similar patients. Extremely high (> 10 000 μg/l) hyperferritinemia is a hallmark of HLH and may enable control of this syndrome which is 100% fatal without treatment.
Authors and Affiliations
Rafał Machowicz, Joanna Drozd-Sokołowska, Dorota Zduńczyk, Barbara Górnicka, Piotr Boguradzki, Wiesław Jędrzejczak
Spotkanie z człowiekiem
W pracy onkologa szczególnie często mamy do czynienia z problemami zmuszającymi nas do trudnych wyborów i podejmowania decyzji, które mają nie tylko wymiar kliniczny, ale może przede wszystkim etyczny. Niestety, zbyt mał...
Toxicity profile of lapatinib plus capecitabine in advanced breast cancer – a single-centre follow-up study
Breast cancer is the most prevalent female neoplasm in Poland as well as in the rest of the world, accounting for 25% of all cancers. Lapatinib is a reversible inhibitor of the HE -1 and HER-2 tyrosine kinase receptors....
Tuberus sclerosis
Rehabilitation of patients with cancer of the respiratory system
Many patients with lung cancer have concomitant chronic obstructive pulmonary disease and heart diseases. The planned anticancer therapy should be individualized in relationship of patient’s cardiac and pulmonary conditi...
Strategia postępowania z chorymi w fazie przewlekłej PBSz w przypadku niepowodzenia leczenia imatynibem – doświadczenia Kliniki Hematologii w Krakowie
Wstęp: Inhibitory kinaz tyrozynowych w sposób celowany eliminują komórki przewlekłej białaczki szpikowej. Pojawiająca się na nie oporność była przyczyną opracowania rekomendacji terapeutycznych oraz leków drugiej i kolej...